Fundamental analysis · SEC EDGAR · TTM through 30/06/2026

Fundamental analysis of Oscar Health, Inc.

OSCR · NYSE · Healthcare

Fundamental quality

ATTRACTIVE

85

out of 100

Oscar Health, Inc. earns a fundamental-quality score of 85 out of 100, profiling it as a company with solid fundamentals. Its score rests mainly on its growth (revenue +89.1%/yr). Its weakest area is its profitability (net margin 3.6%). Whether it's cheap or expensive depends on the current price, which you can compute in the tool.

What the company does

Oscar Health is a digitally native health insurer focused on U.S. individual-market plans (Obamacare/ACA). It competes on a modern user experience against the sector's traditional giants.

What will shape its future

  • Health policy: ACA subsidies define the size and profitability of its market.
  • Members' medical costs versus premiums: every insurer's balancing act.
  • Its ability to grow while keeping pricing discipline in a heavily regulated market.

Breakdown by area

I.Growth
95

Revenue growth: 89.1%

II.Profitability
66

Net margin: 3.6% · ROE: 26.8%

III.Financial health
95

Net debt/EBITDA: -5.54x · FCF: 28.6%

Source: SEC EDGAR · TTM through 30/06/2026

The score combines growth, profitability and financial strength. Here its growth weighs in its favor, while its profitability drags it down the most.

Versus its sector

Percentile against the other 57 Healthcare companies in our coverage: how far it beats them on each metric (100 = best in sector).

Net marginbeats 30%
ROEbeats 80%
Growthbeats 100%
Cash generationbeats 93%
Less debtbeats 98%

Computed from the daily dataset scores. A high percentile places the company among the best in its sector on that metric; it is not a buy recommendation.

Key concepts

What do these metrics mean? Fundamental analysis · What is the P/E · What is EPS · What is ROE · Net & gross margin · Free cash flow

Oscar Health, Inc. strengths

  • Revenue growing strongly (89.1% annualized).
  • Excellent free-cash-flow generation (FCF margin of 28.6%): profit turns into real cash.
  • Outstanding return on equity (ROE of 26.8%): it puts shareholder capital to good use.
  • Revenue rising without interruption since 2020.

Oscar Health, Inc. risks and weaknesses

  • Thin margins (net margin of 3.6%), little cushion for setbacks.
  • Erratic free cash flow, with several years in the red.

Oscar Health, Inc. historical evolution

YearRevenueNet incomeFree cash flowNet debt
2020463-407209-684
20211,839-573-208-1,104
20223,964-606351-1,261
20235,863-271-298-1,572
20249,17825950-1,228
202511,701-4431,058-2,344

Between 2020 and 2025, revenue went from $463M to $11,701M (+2428%) and net income went from -$407M to -$443M (-9%).

Annual figures in millions of U.S. dollars ($M) per SEC filings. Net debt is total debt minus cash.

Latest results

Versus the same period a year earlier

Figures for the half-year ended June 30, 2026, versus the half-year ended June 30, 2025 (SEC filings):

  • Revenue+61.2%
  • Net income+2,118.7%

What changed with the June 30, 2026 results

Compared with the previous close (March 31, 2026), this is what moved in its accounts:

  • Quality score7085
  • Net margin-0.3%3.6%
  • ROE-2.4%26.8%
  • FCF margin21%28.6%
  • Net debt/EBITDA-109.95×-5.54×

Automatic comparison between the two most recent periods filed with the SEC. One quarter doesn't make a trend: read it alongside the historical evolution above.

Dividend

This company doesn't pay a dividend: it reinvests all its earnings back into the business.

Advertising

Want to invest in Oscar Health, Inc.?

Open your account in minutes with regulated brokers and buy U.S. and European stocks from small amounts. No paperwork.

Interactive BrokersGlobal markets

The serious investor's standard

Open free account →
WebullCommission-free

Popular in the U.S.

Open free account →

Investing carries risk of loss.

Is Oscar Health, Inc. cheap or expensive?

That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).

Compute the valuation →

Frequently asked questions

Is Oscar Health, Inc. a good company to invest in?

In terms of business quality, Oscar Health, Inc. scores 85 out of 100 in our analysis, placing it as a company of high fundamental quality. That said, this isn't a recommendation: whether it's a good investment also depends on its current price and your goals.

Is Oscar Health, Inc. a profitable company?

Oscar Health, Inc. is profitable, with a net margin of 3.6%, though a thin one.

Does Oscar Health, Inc. have a lot of debt?

No. Oscar Health, Inc. has a net cash position: more cash than debt.

Is Oscar Health, Inc. growing?

Its revenue has grown 89.1% annualized in recent years, and without interruption since 2020.

Does Oscar Health, Inc. generate cash?

Yes. It converts about 28.6% of its revenue into free cash flow.

The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.

Was this page helpful?